rac erythro Dihydrobupropion-d9

Rac erythro Dihydrobupropion-d9 is a deuterated analog of the dihydro metabolite of bupropion, a compound widely used in research to study the metabolism, pharmacokinetics, and metabolic pathways of bupropion. The presence of deuterium, a heavier isotope of hydrogen, in this analog significantly influences the compound′s metabolic stability and the rate of its biotransformation, providing a tool for researchers to investigate isotope effects on drug metabolism. This compound is particularly valuable in studies employing mass spectrometry, where the deuterium atoms act as markers, enabling precise tracking and differentiation from non-deuterated metabolites. The erythro configuration of this racemic mixture refers to the specific stereoisomeric form, which can exhibit distinct interactions in biological systems compared to other stereoisomers. By using rac erythro Dihydrobupropion-d9 in experimental setups, researchers can gain insights into the stereoselective processes that occur during the metabolism of bupropion and its analogs. Additionally, this compound aids in understanding how deuterium incorporation affects the enzymatic processes involved in the reduction of bupropion, thereby offering a deeper understanding of the metabolic profiles and stability of deuterated versus non-deuterated compounds in both in vitro and in vivo studies.